Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells (2009)
Nakayama, Satoshi, Torikoshi, Yasuhiro, Takahashi, Takeshi, Yoshida, Tomokazu, Sudo, Tamotsu, Matsushima, Tomoko, ...
Abstract Introduction Paclitaxel is used widely in the treatment of breast cancer. Not all tumors respond to this drug, however, and the characteristics that distinguish resistant tumors from...
Yasuhiro Torikoshi, Takeshi Takahashi, Tomokazu Yoshida, Tamotsu Sudo, Tomoko Matsushima, Yuko Kawasaki, ...
PDF corresponds to the article as it appeared upon acceptance. Copyedited and fully formatted PDF and full text (HTML) versions will be made available soon. Prediction of paclitaxel sensitivity by...
Sugimoto, Takeshi, Koizumi, Tamio, Sudo, Tamotsu, Yamaguchi, Satoshi, Kojima, Atsumi, Kumagai, Shunichi, ...
Objectives: Cyclooxygenase-2 (Cox-2) is known to be associated with tumorigenesisin many cancers including endometrial cancer, while there is substantial evidence forthe tumorigenicity of...
Yasuda, Shintaro, Kojima, Atsumi, Maeno, Yoko, Oki, Noriyoshi, Miyahara, Yoshiya, Sudo, Tamotsu, ...
Sudo, Tamotsu, Ota, Yosuke, Kotani, Shuji, Nakao, Mitsuyoshi, Takami, Yasunari, Takeda, Shunichi, ...
Anaphase-promoting complex (APC) is activated by two regulatory proteins, Cdc20 and Cdh1. In yeast and Drosophila, Cdh1-dependent APC (Cdh1–APC) activity targets mitotic cyclins from the end of...
Sudo, Tamotsu, Ota, Yosuke, Kotani, Shuji, Nakao, Mitsuyoshi, Takami, Yasunari, Takeda, Shunichi, ...
Anaphase-promoting complex (APC) is activated by two regulatory proteins, Cdc20 and Cdh1. In yeast and Drosophila, Cdh1-dependent APC (Cdh1–APC) activity targets mitotic cyclins from the end of...